Activator protein-1 in liver pathology: from precancerous diseases to hepatocellular carcinoma

被引：0
作者：
Villarruel-Melquiades, Fernanda [1 ]
Aguirre-Maldonado, Isaac [1 ,2 ]
Herrera-Lopez, Ema Elvira [1 ,2 ]
Mendoza-Garrido, Maria Eugenia [3 ]
Perez-Carreor, Julio Isael [2 ]
Banuelos, Cecilia [4 ]
Camacho, Javier [1 ]
机构：
[1] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Farmacol, Ave IPN 2508, Ciudad De Mexico 07360, Mexico
[2] Inst Nacl Med Genom INMEGEN, Ciudad De Mexico 14610, Mexico
[3] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Ciudad De Mexico 07360, Mexico
[4] Inst Politecn Nacl, Programa Transdisciplinario Desarrollo Cient & Tec, Ctr Invest & Estudios Avanzados, Dept Invest & Estudios Multidisciplinarios, Ciudad De Mexico 07360, Mexico
来源：
HEPATOMA RESEARCH | 2024年 / 10卷
关键词：
Activator protein-1; liver pathology; hepatocellular carcinoma; liver carcinogenesis; transcription factors; VIRUS X-PROTEIN; MATRIX METALLOPROTEINASE-1 EXPRESSION; NF-KAPPA-B; C-JUN; TRANSCRIPTION FACTOR; HEPATITIS-B; CYCLIN D1; MATRIX-METALLOPROTEINASE-9; GENE; CELL-PROLIFERATION; SIGNALING PATHWAY;
D O I：
10.20517/2394-5079.2024.95
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Activator protein 1 (AP-1) is a family of transcription factors composed of Jun, Fos, activating transcription factor (ATF), and musculoaponeurotic fibrosarcoma (MAF) homodimers and heterodimers that regulate diverse cellular processes such as proliferation, apoptosis, differentiation, survival, and migration. Accordingly, AP-1 plays an essential role in several diseases including cancer. During liver cancer development, AP-1 abnormal activation has been implicated from cancer initiation to cancer progression. This review aims to provide a current integrative understanding of the role of AP-1 in liver carcinogenesis and suggests potential settings for its clinical use in diagnosis and treatment. Novel AP-1-based therapeutic approaches deserve further investigation and clinical application for the benefit of liver cancer patients.
引用
收藏
页数：19
相关论文
共 50 条
  • [31] Hepatocellular Carcinoma Surveillance—Experience from Croatian Referral Centre for Chronic Liver Diseases
    Matea Majerović
    Mislav Jelaković
    Marina Premužić
    Ivana Knežević Štromar
    Davor Radić
    Marko Mance
    Stjepko Pleština
    Rajko Ostojić
    Nadan Rustemović
    Zeljko Krznarić
    Journal of Gastrointestinal Cancer, 2019, 50 : 48 - 53
  • [32] Natural killing activities in chronic liver diseases and hepatocellular carcinoma
    Ono, K
    Yamanaga, Y
    Yamamoto, K
    Koga, SI
    Nishimura, J
    Nawata, H
    JOURNAL OF CLINICAL IMMUNOLOGY, 1996, 16 (01) : 41 - 45
  • [33] Histone methylation in pre-cancerous liver diseases and hepatocellular carcinoma: recent overview
    Charidemou, Evelina
    Koufaris, Costas
    Louca, Maria
    Kirmizis, Antonis
    Rubio-Tomas, Teresa
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06) : 1594 - 1605
  • [34] Insulin-like growth factor binding protein-1 inhibits cancer cell invasion and is associated with poor prognosis in hepatocellular carcinoma
    Dai, Bin
    Ruan, Bai
    Wu, Juan
    Wang, Jianlin
    Shang, Runze
    Sun, Wei
    Dou, Kefeng
    Wang, Desheng
    Li, Yu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (09): : 5645 - 5654
  • [35] Programmed Cell Death Protein-1 (PD-1)-Targeted Immunotherapy for Advanced Hepatocellular Carcinoma in Real World
    Cui, Hanzhi
    Dai, Guanghai
    Guan, Jingzhi
    ONCOTARGETS AND THERAPY, 2020, 13 : 143 - 149
  • [36] The Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
    Alonso, Ines Garces de los Fayos
    Liang, Huan-Chang
    Turner, Suzanne D.
    Lagger, Sabine
    Merkel, Olaf
    Kenner, Lukas
    CANCERS, 2018, 10 (04)
  • [37] Activator protein-1 (AP-1) and response to pathogen infection in the Hong Kong oyster (Crassostrea hongkongensis)
    Xiang, Zhiming
    Qu, Fufa
    Li, Jun
    Qi, Lin
    Yang, Zhang
    Kong, Xiaoyu
    Yu, Ziniu
    FISH & SHELLFISH IMMUNOLOGY, 2014, 36 (01) : 83 - 89
  • [38] Cellular retinol binding protein-1 inhibits cancer stemness via upregulating WIF1 to suppress Wnt/β-catenin pathway in hepatocellular carcinoma
    Liu, Xiangye
    Shan, Wenhua
    Li, Tingting
    Gao, Xiaoge
    Kong, Fanyun
    You, Hongjuan
    Kong, Delong
    Qiao, Shuxi
    Tang, Renxian
    BMC CANCER, 2021, 21 (01)
  • [39] Factors related to the development of hepatocellular carcinoma from chronic liver diseases type B and C
    Okanoue, T
    Murakami, Y
    Minami, M
    Itoh, Y
    LIVER CIRRHOSIS, 2001, : 65 - 72
  • [40] Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients
    Na, Keun
    Jeong, Seul-Ki
    Lee, Min Jung
    Cho, Sang Yun
    Kim, Sun A.
    Lee, Min-Ji
    Song, Si Young
    Kim, Hoguen
    Kim, Kyung Sik
    Lee, Hyun Woong
    Paik, Young-Ki
    INTERNATIONAL JOURNAL OF CANCER, 2013, 133 (02) : 408 - 415
12345